Author： Frampton James E.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.72, Iss.10, 2012-07, pp. : 1399-1410
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Catumaxomab delays QOL deterioration in malignant ascites
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 659, 2012-01 ,pp. :
Access to resources
Recommend
By Bellati Filippo Napoletano Chiara Ruscito Ilary Pastore Maria Pernice Milena Antonilli Morena Nuti Marianna Benedetti Panici Pierluigi
Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. :
Drugs, Vol. 69, Iss. 13, 2009-09 ,pp. :
Catumaxomab: Various toxicities following intrapleural administration: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. :
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. :